Literature DB >> 19478654

Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three-months follow-up in a clinical randomized study.

Rikke Rousing1, Mikkel O Andersen, Stig M Jespersen, Karsten Thomsen, Jens Lauritsen.   

Abstract

STUDY
DESIGN: Clinical randomized study.
OBJECTIVE: The aim of this study is to compare percutaneous vertebroplasty (PVP) to conservative treatment of patients with osteoporotic vertebral fractures in a clinical randomized study with respect to pain, physical and mental outcome, and to asses the risk of adjacent fractures. SUMMARY OF BACKGROUND DATA: PVP is a therapeutic procedure performed to reduce pain in vertebral lesions. Despite the lack of comparative randomized clinical trials PVP is generally seen as a safe and efficient procedure for painful osteoporotic fractures.
METHODS: Fifty patients (41 females) were included from January 2001 until January 2008. Patients with acute (<2 weeks) and subacute (between 2 and 8 weeks) osteoporotic fractures were included and randomized to either PVP or conservative treatment. Pain was assessed with a visual analogue scale and physical and mental outcome were assessed by validated questionnaires and tests. Tests, questionnaires, and plain radiographs were performed at the inclusion and after 3 months.
RESULTS: Reduction in pain from initial visit to 3-month follow-up was comparable in the 2 groups (P = 0.33) from approximate visual analogue scale 8.0 to visual analogue scale 2.0, intragroup difference was significant (P = 0.00). Reduction in pain in the PVP group was immediate 12 to 24 hours after the procedure (P = 0.00). There was no significant difference in the other parameters when comparing the results at inclusion and after 3 months within both groups and between the groups after 3 months with a few exceptions. We observed 2 adjacent fractures in the PVP group and non in the conservative group.
CONCLUSION: The majority of patients with acute or subacute painful osteoporotic compression fractures in the spine will recover after a few months of conservative treatment. The risk of adjacent fractures needs further research. No major adverse events were observed.

Entities:  

Mesh:

Year:  2009        PMID: 19478654     DOI: 10.1097/BRS.0b013e3181a4e628

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  58 in total

1.  Percutaneous vertebroplasty in vertebral compression fractures of benign or malignant origin: a prospective study of 1188 patients with follow-up of 12 months.

Authors:  Anastasios Mpotsaris; Razmin Abdolvahabi; Bastian Hoffleith; Janpeter Nickel; Ali Harati; Christian Loehr; Chun Hee Gerdes; Svenja Hennigs; Werner Weber
Journal:  Dtsch Arztebl Int       Date:  2011-05-13       Impact factor: 5.594

2.  Vertebroplasty: a point of view on this surgical treatment.

Authors:  Saccomanni Bernardino
Journal:  Clin Rheumatol       Date:  2010-09-15       Impact factor: 2.980

3.  Is there really no benefit of vertebroplasty for osteoporotic vertebral fractures? A meta-analysis.

Authors:  Ming-Min Shi; Xun-Zi Cai; Tiao Lin; Wei Wang; Shi-Gui Yan
Journal:  Clin Orthop Relat Res       Date:  2012-06-23       Impact factor: 4.176

4.  New vertebral fractures after vertebroplasty: 2-year results from a randomised controlled trial.

Authors:  M P Staples; B M Howe; M D Ringler; P Mitchell; C H R Wriedt; J D Wark; P R Ebeling; R H Osborne; D F Kallmes; R Buchbinder
Journal:  Arch Osteoporos       Date:  2015-08-14       Impact factor: 2.617

5.  The safety and efficacy of percutaneous vertebroplasty for patients over 90 years old.

Authors:  Shunsuke Kamei; Tomoyuki Noguchi; Yoshitaka Shida; Takashi Okafuji; Kota Yokoyama; Fumiya Uchiyama; Hiroshi Nakatake; Tsuyoshi Tajima
Journal:  Jpn J Radiol       Date:  2018-12-01       Impact factor: 2.374

6.  [Can vertebroplasty still be responsibly used for treatment of osteoporotic vertebral fractures? Results of two randomized placebo-controlled trials].

Authors:  W Böcker; M Schieker; D Stengel; C Birkenmaier; S Huber-Wagner; J Rueger; W Mutschler
Journal:  Unfallchirurg       Date:  2010-01       Impact factor: 1.000

7.  Surgery: vertebroplasty: one solution does not fit all.

Authors:  Gunnar B J Andersson
Journal:  Nat Rev Rheumatol       Date:  2009-12       Impact factor: 20.543

8.  The association between the duration of preoperative pain and pain improvement in vertebral augmentation: a meta-analysis.

Authors:  A Ehteshami Rad; M T Luetmer; M H Murad; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-01       Impact factor: 3.825

9.  Vertebroplasty: where do we go from here?

Authors:  Peter L Munk
Journal:  Skeletal Radiol       Date:  2011-04       Impact factor: 2.199

10.  Vertebroplasty for osteoporotic fracture? Think twice.

Authors:  Scott Kinkade; James J Stevermer
Journal:  J Fam Pract       Date:  2009-12       Impact factor: 0.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.